Blog
Enterprise RWE Adoption: Aetion’s Maturity Model for Integration and Leadership
Ashley Jaksa, MPH and Natalie Schibell, MPH Real-World Evidence (RWE) has evolved from ...
Blog
Aetion Recognized as a Leader in CB Insights’ Synthetic Patient Data Market Analysis
Aetion has been named a Leader in CB Insights’ Synthetic Patient Data Market Analysis, ...
Blog
One Year of Aetion® Discover: Driving Innovation in Real-World Evidence Generation
Real-world data (RWD) presents significant complexities that require solutions that blend ...
Blog
Aetion® Substantiate Spotlight: Turning Dosing Complexity Into Actions
Blog authored by: Michelle Skornicki, MPH; Natalie Schibell, MPH; Pippa Hodgkins; Renee ...
Blog
2024 in Review: Aetion’s Impact on Real-World Evidence Generation
In 2024, Aetion continued to redefine real-world evidence (RWE) generation by combining ...
Blog
Advancing Evidence: Insights from the 43rd Annual J.P. Morgan Healthcare Conference
The 43rd Annual J.P. Morgan Healthcare Conference provided a platform for thoughtful ...
Blog
Custom Analyses: Elevating Aetion® Substantiate’s Capabilities for Tailored Research
Blog
Key Takeaways from the 43rd Annual J.P. Morgan Healthcare Conference
The 43rd Annual J.P. Morgan Healthcare Conference, held from January 13-16, 2025, in San ...
Blog
Aetion Generate 3.6: Privacy Meets Scientific Rigor in Real-World Evidence
At Aetion®, we ensure privacy concerns and compliance hurdles never stand in the way of ...
Blog
Feature Spotlight: Transforming RWD Management with Measures Assistant (Beta)
Real-world data (RWD) is the lifeblood of modern healthcare research, driving ...
Blog
FDA Expands Dupixent Approval for Adolescents with Chronic Rhinosinusitis with Nasal Polyps, Leveraging RWE Powered by Aetion® Substantiate
Blog authored by:
Blog
Driving Innovation in HTA Decision-Making: Aetion participates in RWE4Decisions' 2024 Stakeholder Actions
On November 14th, RWE4Decisions hosted its annual Symposium, this year focusing on how to ...
Blog
Own the Future of Healthcare: Aetion’s AI/ML Tools Turn Data Into Impact
Healthcare stands at a crossroads. The pressure to deliver better care at lower costs is ...
Blog
Applying AI to RWE and Drug Development
With applications abound, AI is poised to change how RWD/RWE teams operate and how ...
Blog
What’s Next for Healthcare in 2025: Emerging Threats, GLP-1 Inhibitors, AI, and the Power of RWE
As 2024 comes to a close and 2025 gets going, major changes in healthcare and drug ...
Blog
How RWE can Impact R&D and Beyond
Real-world data (RWD) and real-world evidence (RWE) continue to positively impact drug ...
Blog
Bringing Patients Front and Center in RWD/RWE
The ultimate goal of using real-world data (RWD) to generate real-world evidence (RWE) is ...
Blog
Webinar recap: The Goldilocks problem in oncology RWD: choosing the data that’s ‘just right’
We all know that, in the story of Goldilocks and the Three Bears, it took the young girl ...
Blog
Advancing Pharmacoepidemiology at ICPE 2024
Aetion joins experts from around the world at ICPE 2024 to discuss advances in ...
Blog
Efficient Synthesis of Complex Health Data
Blog authored by Lucy Mosquera (Sr. Director, Generate Operations and Data Science) and ...
Blog
Advancing SMA Treatment: How Real-World Evidence Supports Regulatory Decisions
Spinal Muscular Atrophy (SMA) is a rare and debilitating neuromuscular disease affecting ...
Blog
Quality, Rigor, and Transparency: The RWE Imperative
Over the past year, news stories have focused on high-profile missteps or fraud in the ...
Blog
The Evolving Role of Observational Studies in Healthcare: Enhancing Payer Utility and Impact
Blog authored by Ashley Jaksa (VP, Scientific Strategy & Partnerships) and Pat Arena ...
Blog
Navigating the European Union's Medical Device Regulation (MDR)
On May 26, 2021 the European Union’s (EU) Medical Device Regulation (MDR) became ...